Local government units (LGU) are nowadays facing the very difficult and complicated task of making reasonable decisions regarding the transforming of SPZOZs into capital companies. First, it seems necessary to carry out a simulation of costs and advantages of the assumed models and solutions...

A regional disparity is becoming increasingly important growth constraint. Policy makers need quantitative knowledge to design effective and targeted policies. In this paper, the regional efficiency of healthcare facilities in Slovakia is measured (2008-2015) using data envelopment analysis...

Although cancer survival in general has improved in Australia over the past 30 years, Indigenous Australians, socioeconomically disadvantaged persons, and people living in remote areas still experience poorer health outcomes. This paper aims to describe the development of CancerCostMod, and to...

The Health sector, as a part of the national economy, is extremely important for economic development. A well organized and operating healthcare system constitutes an important notion for both patients and national policy. That is why the organisation of healthcare systems is the subject of...

The purpose of the present paper is to analyse the changes that occurred in the Romanian medical system since the communism’s collapse and until nowadays and to determine the evolution of the population’s health status during this period. During the last 25 years, the public Romanian...

The purpose of this study is to evaluate and compare the efficiency of healthcare systems among 28 countries around the world by applying the data envelopment analysis (DEA) method. Two output variables are used: life expectancy at birth and infant mortality rate. Four input variables are used:...

The EU approved the first biosimilar drug in 2006. By 2017, the EU had authorized the highest number of biosimilars worldwide, acquiring considerable experience in their use and safety. In May 2019, the European Medicines Agency (EMA) search engine showed 54 authorized biosimilars. Biosimilars...

Background: The use of research evidence to inform policy and practice cannot be overemphasized especially in low and middle-income countries (LMICs). To promote the use of research evidence in the provision of health services for enhanced effective control of communicable diseases in developing...